"We don't need services. We have no problems": exploring the experiences of young people who inject drugs in accessing harm reduction services

Journal of the International AIDS Society
Anita KrugNina Sun

Abstract

Evidence suggests that people who inject drugs often begin their drug use and injecting practices in adolescence, yet there are limited data available on the HIV epidemic and the responses for this population. The comprehensive package of interventions for the prevention, treatment and care of HIV infection among people who inject drugs first laid out in 2009 (revised in 2012) by World Health Organization, United Nations Office of Drugs and Crime and Joint United Nations Programme on HIV/AIDS, does not consider the unique needs of adolescent and young people. In order to better understand the values and preferences of young people who inject drugs in accessing harm reduction services and support, we undertook a series of community consultations with young people with experience of injecting drugs during adolescence. Community consultations (4-14 persons) were held in 14 countries. Participants were recruited using a combined criterion and maximum variation sampling strategy. Data were analyzed using collaborative qualitative data analysis. Frequency analysis of themes was conducted. Nineteen community consultations were organized with a total of 132 participants. All participants had experienced injecting drugs before the age o...Continue Reading

References

Mar 31, 1998·Addiction·J S FennemaR A Coutinho
Aug 10, 2000·Journal of Acquired Immune Deficiency Syndromes : JAIDS·A H KralB R Edlin
Mar 4, 2003·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Jennifer L EvansAndrew R Moss
Jun 29, 2005·American Journal of Public Health·Neal Dickert, Jeremy Sugarman
Dec 20, 2007·AIDS·Dmitry M KissinSusan Hillis
Feb 14, 2009·AIDS and Behavior·V Anna GyarmathyCarl A Latkin
Nov 26, 2009·The International Journal on Drug Policy·Sherly M ParackalJohn A Harraway
Dec 29, 2009·The International Journal on Drug Policy·Simona MerkinaiteAllen Frimpong
Apr 10, 2010·Central European Journal of Public Health·Nadja Kehler CurthJeffrey V Lazarus
Jul 24, 2010·Lancet·Grant ColfaxCarl Hart
May 3, 2011·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Kora DebeckThomas Kerr
Apr 1, 2011·SAHARA J : Journal of Social Aspects of HIV/AIDS Research Alliance·Rena Greifinger, Bruce Dick
Apr 10, 2013·The International Journal on Drug Policy·Joanna BuszaDanijela Simic
Sep 24, 2013·Drug and Alcohol Dependence·Dan WerbEvan Wood

❮ Previous
Next ❯

Citations

Jul 18, 2012·PLoS Neglected Tropical Diseases·Jon J VermeireConor R Caffrey
Mar 1, 2015·Journal of the International AIDS Society·Linda-Gail BekkerSybil Hosek
Nov 30, 2016·Substance Abuse Treatment, Prevention, and Policy·Elliott J LieblingBrandon D L Marshall
Jan 5, 2017·The American Journal on Addictions·Jesse L YedinakBrandon D L Marshall
Nov 30, 2018·Substance Abuse Treatment, Prevention, and Policy·Tessa ChengKora DeBeck
Mar 29, 2020·Harm Reduction Journal·Cynthia Semá BaltazarTimothy Kellogg
Jan 3, 2021·Pediatrics·Simeon D KimmelBrandon D L Marshall

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.